Alzheimer disease trials in Finland

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  Where

  Helsinki, Kuopio, Oulu, Turku

  Age

  60 years to 85 years

  People

  586 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06976203 · EU 2025-520747-32-00
• No phaseTaking people
  Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

  Where

  Kuopio

  Age

  18 years and over

  People

  200

  Run by

  Kuopio University Hospital

  See details and how to joinNCT05326750
• Phase 4Taking people
  A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

  Where

  Espoo, Helsinki, Jarvenpaa, Kokkola, Oulu, Seinäjoki, Tampere, Turku

  Age

  76 years and over

  People

  33,609

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07502560 · EU 2025-524598-17-00
• Phase 2Taking people
  Open-label Extension Study in Participants With Early Alzheimer's Disease

  Where

  Oulu

  Age

  50 years to 85 years

  People

  220 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07105709